Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ying Chang, Li-Bo Wang, Dan Li, Ke Lei & Song-Yan Liu. (2017) Efficacy of rasagiline for the treatment of Parkinson’s disease: an updated meta-analysis. Annals of Medicine 49:5, pages 421-434.
Read now
Read now
Mehri Hasani & Masoud Ghods. Predicting the physicochemical properties of drugs for the treatment of Parkinson's disease using topological indices and MATLAB programming. Molecular Physics 0:0.
Read now
Read now
Articles from other publishers (17)
Tapan Behl, Piyush Madaan, Aayush Sehgal, Hafiz A. Makeen, Mohammed Albratty, Hassan A. Alhazmi, Abdulkarim M. Meraya, Md. Khalid Anwer & Raman Verma. (2023) Understanding the Molecular Aspects of Vitamins in Parkinson’s Disease:
Present-day Concepts and Perspectives. Current Pharmaceutical Design 29:19, pages 1467-1485.
Crossref
Crossref
Panayiota Michael, Sandra Blythin Constantinou Juhasz, Olympia Evagorou, Lilia Psalta & Georgios Mikellides. (2022) High-frequency rTMS improves quality of life and depressive symptoms in Parkinson’s disease: A case report. Heliyon 8:12, pages e12196.
Crossref
Crossref
Alexander Leathem, Tamara Ortiz-Cerda, Joanne M. Dennis & Paul K. Witting. (2022) Evidence for Oxidative Pathways in the Pathogenesis of PD: Are Antioxidants Candidate Drugs to Ameliorate Disease Progression?. International Journal of Molecular Sciences 23:13, pages 6923.
Crossref
Crossref
Ahmet Hüsamettin BARAN. (2022) ANTİPARKİNSON İLAÇLARINA VERİLEN BİREYSEL YANITTA FARMAKOGENETİĞİN ROLÜ. Ankara Universitesi Eczacilik Fakultesi Dergisi, pages 523-536.
Crossref
Crossref
Alexander Leathem, Martin Simone, Joanne M. Dennis & Paul K. Witting. (2022) The Cyclic Nitroxide TEMPOL Ameliorates Oxidative Stress but Not Inflammation in a Cell Model of Parkinson’s Disease. Antioxidants 11:2, pages 257.
Crossref
Crossref
Ezra Michelet Garcia-Romero, Edgar López-López, Catalina Soriano-Correa, José L. Medina-Franco & Carolina Barrientos-Salcedo. (2022) Polypharmacological drug design opportunities against Parkinson's disease. F1000Research 11, pages 1176.
Crossref
Crossref
Mark S. Moehle, Aaron M. Bender, Jonathan W. Dickerson, Daniel J. Foster, Aidong Qi, Hyekyung P. Cho, Yuping Donsante, Weimin Peng, Zoey Bryant, Kaylee J. Stillwell, Thomas M. Bridges, Sichen Chang, Katherine J. Watson, Jordan C. O’Neill, Julie L. Engers, Li Peng, Alice L. Rodriguez, Colleen M. Niswender, Craig W. Lindsley, Ellen J. Hess, P. Jeffrey Conn & Jerri M. Rook. (2021)
Discovery of the First Selective M
4
Muscarinic Acetylcholine Receptor Antagonists with
in Vivo
Antiparkinsonian and Antidystonic Efficacy
. ACS Pharmacology & Translational Science 4:4, pages 1306-1321.
Crossref
Crossref
Teresa Capriello, Sandra M. Monteiro, Luis M. Félix, Aldo Donizetti, Vincenza Aliperti & Ida Ferrandino. (2021) Apoptosis, oxidative stress and genotoxicity in developing zebrafish after aluminium exposure. Aquatic Toxicology 236, pages 105872.
Crossref
Crossref
Danielle Paige Anthony, Manasa Hegde, Shreya S. Shetty, Thasneema Rafic, Srinivas Mutalik & B.S. Satish Rao. (2021) Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases. Life Sciences 274, pages 119326.
Crossref
Crossref
Paulina Bastian, Jaroslaw Dulski, Anna Roszmann, Dagmara Jacewicz, Alicja Kuban-Jankowska, Jaroslaw Slawek, Michal Wozniak & Magdalena Gorska-Ponikowska. (2021) Regulation of Mitochondrial Dynamics in Parkinson’s Disease—Is 2-Methoxyestradiol a Missing Piece?. Antioxidants 10:2, pages 248.
Crossref
Crossref
Sikander Khan, Farida Khan, Qurat Ul Ain Sikander, Muhammad Mansoor Alam & Mazliham Mohd Su'Ud. (2021) Intelligent Deep Brain Stimulation Systems: A General Review. IEEE Access 9, pages 136929-136943.
Crossref
Crossref
Trisha Bhatt, Bhoomika M. Patel & Mayur M. Patel. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
491
513
.
Degirmenci Husnu, Bakirci Eftal Murat & Hamur Hikmet. (2020) Cardiac Effects of Parkinson’s Disease. Open Journal of Parkinson's Disease and Treatment, pages 006-007.
Crossref
Crossref
Bor-Yann Chen, Yun-Chen Wu, Yu-Hsiu Lin, Lemmuel Lara Tayo, Arjay Christopher Tacas & Chung-Chuan Hsueh. (2020) Deciphering Electron-Shuttling Characteristics of Parkinson’s Disease Medicines via Bioenergy Extraction in Microbial Fuel Cells. Industrial & Engineering Chemistry Research 59:39, pages 17124-17136.
Crossref
Crossref
Benedicta Obenewaa Dankyi, Seth Kwabena Amponsah, Grace Lovia Allotey-Babington, Ismaila Adams, Nana Aboadwe Goode & Henry Nettey. (2020) Chitosan-Coated Hydroxypropylmethyl Cellulose Microparticles of Levodopa (and Carbidopa): In Vitro and Rat Model Kinetic Characteristics. Current Therapeutic Research 93, pages 100612.
Crossref
Crossref
Panchanan Maiti, Jayeeta Manna & Gary L. Dunbar. (2017) Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments. Translational Neurodegeneration 6:1.
Crossref
Crossref
Panayiota Michael, Sandra Blythin Constantinou Juhasz, Olympia Evagorou, Lilia Psalta & Georgios Mikellides. (2022) High- Frequency Rtms Improves Quality of Life and Depressive Symptoms in Parkinson's Disease: A Case Report. SSRN Electronic Journal.
Crossref
Crossref